CELC
Get informed when a big investor buys or sells
+ FollowOvervalued by 100.6% based on the discounted cash flow analysis.
| Market cap | $6.48 Billion |
|---|---|
| Enterprise Value | $6.53 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.78 |
| Beta | 0.09 |
| Outstanding Shares | 54,462,826 |
| P/E Ratio | -37.52 |
|---|---|
| PEG | -87.61 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 42405.53 |
| Enterprise Value to EBIT | -38.82 |
| Enterprise Value to Net Income | -34 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 3.65 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2810▲ 16.44% |
|---|---|
| Total Calls | 1,845,945▲ 59.88% |
| Total Puts | 518,800▲ 285.15% |
Holdings and activity of institutional investors.
| Ownership % | 93.33%▼ 14.03% |
|---|---|
| Total Invested | $5.58B▲ 16.03% |
| Investors Holding | 292▲ 41.00% |
No data
This committee provides crucial 'revenue estimates' for all tax legislation, directly influencing corporate tax structures and capital investment credits. Its technical expertise and scoring function have a direct and significant impact on the financial burden and strategy for all companies, including Celcuity.
This powerful committee controls taxation, trade, and entitlement spending, including Medicare. Decisions on Medicare pricing and reimbursement rates for diagnostic tests are a primary driver of revenue and profitability for medical laboratories like Celcuity.
This committee allocates discretionary federal spending. Its subcommittees determine precise funding for scientific research, public health initiatives, and federal healthcare programs, directly affecting potential grants, contracts, and revenue streams for medical laboratories.
This committee directly regulates the FDA and NIH. The FDA's oversight of diagnostic tests (including Lab Developed Tests and IVDs) is paramount to medical laboratories, and NIH funding is a major driver of medical research in which labs participate.
This committee oversees antitrust laws and intellectual property. Intellectual property (patents for diagnostic tests and methodologies) is critical for medical laboratories, and antitrust oversight could impact potential mergers and acquisitions in the industry.
This committee oversees the Department of Veterans Affairs. Funding decisions and policies directly impact government healthcare contractors, meaning Celcuity could be significantly affected if it provides diagnostic services or research to the VA.